MD Anderson Cancer Center SPORE in Head and Neck Cancer

MD 安德森癌症中心 SPORE 在头颈癌中的应用

基本信息

  • 批准号:
    6801959
  • 负责人:
  • 金额:
    $ 235.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-09-30 至 2007-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The University of Texas M. D. Anderson Cancer Center is proposing a Specialized Program of Research Excellence (SPORE) in head and neck cancer. The primary goal of this research program is to cultivate and facilitate innovative and significant translational research in the biologic, genetic and clinical aspects of early detection, prevention and treatment of head and neck cancer. These efforts will lead to changes in clinical practice that favorably impact mortality and morbidity of patients with cancer and decrease the incidence of head and neck cancer. The multidisciplinary group of distinguished investigators assembled for this research program will accomplish this goal through effective and collaborative integration of laboratory, epidemiologic and clinical investigations. Such activity will further our understanding of genetic susceptibility and the tumorigenic process in target tissue, leading to novel, molecularly-targeted strategies for the treatment and prevention of head and neck cancer. As outlined below, the program is designed with five research projects and three core resources, as well as programs for developmental research and career development. The research projects are designed to target specific areas important in head and neck cancer, as well as cancers at other disease sites. Project 1: Genetic Susceptibility Markers in Surrogate and Target Tissues Project 2: Targeting Angiogenesis for Therapy of Head and Neck Cancer Project 3: Targeting EGFR for Chemoprevention of Head and Neck Cancer Project 4: Targeting the p53 Pathway for Reversal of Oral Premalignancy Project 5: Targeting Induction of Apoptosis for Therapy of Head and Neck Cancer Core : Biostatistics and Data Management Core : Tissue Procurement and Pathology Developmental Research Program and Career Development Program Through this research program, our research team will make a significant impact on prevention and clinical care of patients with head and neck cancer. We will bring all of our resources to bear on this problem.
描述(由申请人提供):德克萨斯大学安德森博士

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Waun Ki Hong其他文献

Testis Tumor Markers: How Accurate are They?
  • DOI:
    10.1016/s0022-5347(17)55155-1
  • 发表时间:
    1981-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Ralph deVere White;Steven Karian;Waun Ki Hong;Carl A. Olsson
  • 通讯作者:
    Carl A. Olsson
Pharmacology, Clinical Efficacy and Adverse Effects of Vindesine Sulfate, A New Vinca Alkaloid
新长春花生物碱硫酸长春地辛的药理、临床疗效及不良反应
The incidence of hypercalcemia in squamous cell carcinoma of the head and neck.
头颈部鳞状细胞癌高钙血症的发生率。
  • DOI:
  • 发表时间:
    1984
  • 期刊:
  • 影响因子:
    0
  • 作者:
    E. Dorman;H. Yang;C. Vaughan;W. Hong;Waun Ki Hong;Strong Ms
  • 通讯作者:
    Strong Ms
Rapidly Expanding Retroperitoneal Mass
  • DOI:
    10.1016/s0022-5347(17)56019-x
  • 发表时间:
    1980-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Carl A. Olsson;Enrique Soto;Stephen Gerzof;Waun Ki Hong;Neal K. Anderson
  • 通讯作者:
    Neal K. Anderson
Familial intraocular malignant melanoma. A Case Report
家族性眼内恶性黑色素瘤。
  • DOI:
  • 发表时间:
    1978
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    Glenn J. Green;Waun Ki Hong;J. Everett;Rakesh Bhutani;Robert M. Amick
  • 通讯作者:
    Robert M. Amick

Waun Ki Hong的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Waun Ki Hong', 18)}}的其他基金

MD Anderson Cancer Center SPORE in Head and Neck Cancer
MD 安德森癌症中心 SPORE 在头颈癌中的应用
  • 批准号:
    6665523
  • 财政年份:
    2002
  • 资助金额:
    $ 235.16万
  • 项目类别:
MD Anderson Cancer Center SPORE in Head and Neck Cancer
MD 安德森癌症中心 SPORE 在头颈癌中的应用
  • 批准号:
    7112910
  • 财政年份:
    2002
  • 资助金额:
    $ 235.16万
  • 项目类别:
MD Anderson Cancer Center SPORE in Head and Neck Cancer
MD 安德森癌症中心 SPORE 在头颈癌中的应用
  • 批准号:
    6531499
  • 财政年份:
    2002
  • 资助金额:
    $ 235.16万
  • 项目类别:
MD Anderson Cancer Center SPORE in Head and Neck Cancer
MD 安德森癌症中心 SPORE 在头颈癌中的应用
  • 批准号:
    6951910
  • 财政年份:
    2002
  • 资助金额:
    $ 235.16万
  • 项目类别:
Impact of Smoking on Lung Cancer Chemoprevention
吸烟对肺癌化学预防的影响
  • 批准号:
    6646587
  • 财政年份:
    2001
  • 资助金额:
    $ 235.16万
  • 项目类别:
Impact of Smoking on Lung Cancer Chemoprevention
吸烟对肺癌化学预防的影响
  • 批准号:
    6793673
  • 财政年份:
    2001
  • 资助金额:
    $ 235.16万
  • 项目类别:
Impact of Smoking on Lung Cancer Chemoprevention
吸烟对肺癌化学预防的影响
  • 批准号:
    6360029
  • 财政年份:
    2001
  • 资助金额:
    $ 235.16万
  • 项目类别:
Impact of Smoking on Lung Cancer Chemoprevention
吸烟对肺癌化学预防的影响
  • 批准号:
    6949040
  • 财政年份:
    2001
  • 资助金额:
    $ 235.16万
  • 项目类别:
Impact of Smoking on Lung Cancer Chemoprevention
吸烟对肺癌化学预防的影响
  • 批准号:
    6522695
  • 财政年份:
    2001
  • 资助金额:
    $ 235.16万
  • 项目类别:
CHEMOPREVENTION OF SECOND PRIMARY TUMORS WITH 13-CIS RETINOIC ACID
用 13-顺式视黄酸化学预防第二原发肿瘤
  • 批准号:
    6300362
  • 财政年份:
    2000
  • 资助金额:
    $ 235.16万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了